# HD11 for Intermediate Stages

> **NCT00264953** · PHASE3 · COMPLETED · sponsor: **University of Cologne** · enrollment: 1395 (actual)

## Conditions studied

- Hodgkin´s Lymphoma

## Interventions

- **DRUG:** Adriamycin
- **DRUG:** Bleomycin
- **DRUG:** Vinblastine
- **DRUG:** DTIC
- **DRUG:** Etoposide
- **DRUG:** Procarbazine
- **DRUG:** Prednisone
- **DRUG:** Vincristine
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00264953
- **Lead sponsor:** University of Cologne
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-05
- **Primary completion:** 2003-01
- **Final completion:** —
- **Target enrollment:** 1395 (ACTUAL)
- **Last updated:** 2011-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264953, "HD11 for Intermediate Stages". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00264953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*